Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: A prospective, multicenter, randomized controlled trial

BMC Health Services Research

Volumn 7, Issue , 2007, Pages

  Schuetz, Philipp ^a,b   Christ Crain, Mirjam ^a   Wolbers, Marcel ^b   Schild, Ursula ^a   Thomann, Robert ^a,c   Falconnier, Claudine ^a,d   Widmer, Isabelle ^f   Neidert, Stefanie ^f   Blum, Claudine A ^e   Schönenberger, Ronald ^c   Henzen, Christoph ^f   Bregenzer, Thomas ^e   Hoess, Claus ^g   Krause, Martin ^g   Bucher, Heiner C ^b   Zimmerli, Werner ^d   Müller, Beat ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Departement of Internal Medicine   (Switzerland)

^d Kantonsspital Liestal   (Switzerland)

^e University Department of Internal Medicine   (Switzerland)

^f Departement of Internal Medicine   (Switzerland)

^g Kantonsspital Muensterlingen   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN; ANTIINFECTIVE AGENT; BACTERIUM ANTIBODY; CALCITONIN; GLYCOPROTEIN; PROTEIN PRECURSOR;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OPEN STUDY; PATIENT ASSESSMENT; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STRUCTURED INTERVIEW; SWITZERLAND; TREATMENT OUTCOME; AGED; BLOOD; DRUG MONITORING; DRUG USE; FEMALE; MALE; MICROBIOLOGY; MIDDLE AGED; PATIENT SELECTION; QUESTIONNAIRE; RESPIRATORY TRACT INFECTION; STATISTICS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; CALCITONIN; DRUG MONITORING; DRUG UTILIZATION REVIEW; FEMALE; GLYCOPROTEINS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT DISCHARGE; PATIENT SELECTION; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; QUESTIONNAIRES; RESPIRATORY TRACT INFECTIONS; SWITZERLAND;

EID: 34547911350     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-7-102     Document Type: Article

References (38)

1. Economic costs of respiratory tract infections in the United States. RE Dixon, Am J Med 1985 78 45 51 10.1016/0002-9343(85)90363-8 4014287
2. Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community. JT Macfarlane A Colville A Guion RM Macfarlane DH Rose, Lancet 1993 341 511 514 10.1016/0140-6736(93)90275-L 8094769
3. A prediction rule to identify low-risk patients with community-acquired pneumonia. MJ Fine TE Auble DM Yealy BH Hanusa LA Weissfeld DE Singer CM Coley TJ Marrie WN Kapoor, N Engl J Med 1997 336 243 250 10.1056/NEJM199701233360402 8995086
4. How should we make the admission decision in community-acquired pneumonia? D Aronsky NC Dean, Med Clin North Am 2001 85 1397 1411 10.1016/S0025-7125(05)70387-4 11680109
5. Assessing the quality of clinical data in a computer-based record for calculating the pneumonia severity index. D Aronsky PJ Haug, J Am Med Inform Assoc 2000 7 55 65 10641963
6. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. WS Lim MM van der Eerden R Laing WG Boersma N Karalus GI Town SA Lewis JT Macfarlane, Thorax 2003 58 377 382 10.1136/thorax.58.5.377 12728155
7. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. L Simon F Gauvin DK Amre P Saint-Louis J Lacroix, Clin Infect Dis 2004 39 206 217 10.1086/421997 15307030
8. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. B Muller S Harbarth D Stolz R Bingisser C Mueller J Leuppi C Nusbaumer M Tamm M Christ-Crain, BMC Infect Dis 2007 7 10 17335562 10.1186/1471-2334-7-10
9. Procalcitonin in bacterial infections - hype, hope, more or less? M Christ-Crain B Muller, Swiss Med Wkly 2005 135 451 460 16208582
10. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. S Gibot A Cravoisy B Levy MC Bene G Faure PE Bollaert, N Engl J Med 2004 350 451 458 10.1056/NEJMoa031544 14749453
11. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. M Christ-Crain D Jaccard-Stolz R Bingisser MM Gencay PR Huber M Tamm B Muller, Lancet 2004 363 600 607 10.1016/S0140-6736(04)15591-8 14987884
12. Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia: A Randomized Trial. M Christ-Crain D Stolz R Bingisser C Muller D Miedinger PR Huber W Zimmerli S Harbarth M Tamm B Muller, Am J Respir Crit Care Med 2006 174 84 93 10.1164/rccm.200512-1922OC 16603606
13. Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671]. M Briel M Christ-Crain J Young P Schuetz P Huber P Periat HC Bucher B Muller, BMC Fam Pract 2005 6 34 16107222 10.1186/1471-2296-6-34
14. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. D Stolz M Christ-Crain R Bingisser J Leuppi D Miedinger C Muller P Huber B Muller M Tamm, Chest 2007 131 9 19 10.1378/chest.06-1500 17218551
15. "Kennzahlen der Schweizer Spitäler 2004". Bundesamt für Gesundheit (BAG) EDdI, 2006 http://www.bag.admin.ch
16. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. MS Niederman LA Mandell A Anzueto JB Bass WA Broughton GD Campbell N Dean T File MJ Fine PA Gross F Martinez TJ Marrie JF Plouffe J Ramirez GA Sarosi A Torres R Wilson VL Yu, Am J Respir Crit Care Med 2001 163 1730 1754 11401897
17. Guidelines for the management of adult lower respiratory tract infections. M Woodhead F Blasi S Ewig G Huchon M Leven A Ortqvist T Schaberg A Torres G van der Heijden TJ Verheij, Eur Respir J 2005 26 1138 1180 10.1183/09031936.05.00055705 16319346
18. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. NR Anthonisen J Manfreda CP Warren ES Hershfield GK Harding NA Nelson, Ann Intern Med 1987 106 196 204 3492164
19. Chronic obstructive pulmonary disease. PM Calverley P Walker, Lancet 2003 362 1053 1061 10.1016/S0140-6736(03)14416-9 14522537
20. Uncomplicated acute bronchitis. R Gonzales MA Sande, Ann Intern Med 2000 133 981 991 11119400
21. http://prohosp.easysolution.ch
22. Validating the EQ-5D with time trade off for the German population. W Greiner C Claes JJ Busschbach JM Graf von der Schulenburg, Eur J Health Econ 2004 15614535
23. Global initiative for chronic obstructive lung disease, updated 2003. http://www.goldcopd.com
24. Copeptin, C-Reactive Protein, and Procalcitonin as Prognostic Biomarkers in Acute Exacerbation of COPD. D Stolz M Christ-Crain NG Morgenthaler J Leuppi D Miedinger R Bingisser C Muller J Struck B Muller M Tamm, Chest 2007 131 1058 1067 10.1378/chest.06-2336 17426210
25. Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. NG Morgenthaler J Struck M Christ-Crain A Bergmann B Muller, Crit Care 2005 9 R37 45 15693965 10.1186/cc3015
26. Measurement of Serum Free Cortisol Shows Discordant Responsivity to Stress and Dynamic Evaluation. M Christ-Crain S Jutla I Widmer O Couppis C Konig H Pargger J Puder R Edwards B Muller AB Grossman, J Clin Endocrinol Metab 2007 92 5 1729 1735 10.1210/jc.2006-2361 17341561
27. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. NG Morgenthaler B Mueller J Struck A Bergmann H Redl M Christ-Crain, Shock 2007
28. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. M Christ-Crain NG Morgenthaler J Struck S Harbarth A Bergmann B Muller, Crit Care 2005 9 R816 824 16356231 10.1186/cc3885
29. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. M Christ-Crain NG Morgenthaler D Stolz C Muller R Bingisser S Harbarth M Tamm J Struck A Bergmann B Muller, Crit Care 2006 10 R96 103 16805922 10.1186/cc4443
30. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. NG Morgenthaler J Struck C Alonso A Bergmann, Clin Chem 2005 51 1823 1829 10.1373/clinchem.2005.051110 16099941
31. A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. T Eto, Peptides 2001 22 1693 1711 10.1016/S0196-9781(01)00513-7 11754955
32. Cardiac hormones as diagnostic tools in heart failure. H Ruskoaho, Endocr Rev 2003 24 341 356 10.1210/er.2003-0006 12788803
33. B-type natriuretic peptide for risk stratification in community-acquired pneumonia. C Mueller K Laule-Kilian A Scholer AP Perruchoud, J Intern Med 2005 258 391 393 10.1111/j.1365-2796.2005.01540.x 16164581
34. Immunoluminometric assay for the midregion of pro-atrial natriuretic Peptide in human plasma. NG Morgenthaler J Struck B Thomas A Bergmann, Clin Chem 2004 50 234 236 10.1373/clinchem.2003.021204 14709661
35. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections. B Muller E Suess P Schuetz C Muller R Bingisser A Bergmann D Stolz M Tamm NG Morgenthaler M Christ-Crain, J Intern Med 2006 260 568 576 10.1111/j.1365-2796.2006.01722.x 17116008
36. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. NG Morgenthaler J Struck C Alonso A Bergmann, Clin Chem 2006 52 112 119 10.1373/clinchem.2005.060038 16269513
37. Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. B Muller N Morgenthaler D Stolz P Schuetz C Muller R Bingisser A Bergmann M Tamm M Christ-Crain, Eur J Clin Invest 2007 37 145 152 10.1111/j.1365-2362.2007.01762.x 17217381
38. CAPNETZ-community-acquired pneumonia competence network. T Welte N Suttorp R Marre, Infection 2004 32 234 238 10.1007/s15010-004-3107-z 15293080